By Lori Maricle, College of Pharmacy
The committee represents the interests of consumers and consumer organizations in advising the FDA commissioner on the safety and effectiveness of drug products submitted for approval for human use, specifically the marketed and investigational drug therapies that treat arthritis, rheumatism and related diseases.
“I look forward to representing our profession and Washington State University through this important role with the FDA in service to the American public,” Baker said.
He served on the national pharmacy and therapeutics committee for Medco Health Solutions for over 18 years. He is a fellow of the American Society of Consultant Pharmacists and the American Society of Hospital Pharmacists.
He is a pharmacotherapy professor and the associate dean for professional and continuing education at the WSU College of Pharmacy where he teaches student pharmacists about drug therapy, drug information and evidence based medicine.
As director of the WSU Drug Information Center, Baker supervises two post-graduate doctor of pharmacy residents specializing in drug information and pharmacy education. The center serves as a reference resource on drug-related questions to health care providers and is the primary support unit for Wolters Kluwer Health’s Formulary Monograph Service (FMS).
Wolters Kluwer Health is a drug and health information publisher, and the FMS is a resource used in the formulary decision-making process for hospitals and managed care systems on recently released and investigational drugs.
Baker has received numerous awards and honors including the Smith, Kline & French Laboratories Award for Superior Achievement in Clinical Pharmacy, the Washington State Pharmacy Association Pharmacist of the Year and a WSU Faculty Excellence Award.